These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 21053477)

  • 1. [On-demand treatment of nonerosive reflux disease: omeprazole plus bicarbonate powder versus omeprazole capsules].
    Soifer L; Pedrana R; Parrota M; Gadea O; Naisberg G; Caruso N
    Acta Gastroenterol Latinoam; 2010 Sep; 40(3):198-205. PubMed ID: 21053477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Omeprazole or ranitidine for intermittent treatment of GERD?
    Salzberg SA; Newton WP
    J Fam Pract; 1999 May; 48(5):332-3. PubMed ID: 10334603
    [No Abstract]   [Full Text] [Related]  

  • 3. [Gastric acid suppression of a new oral powder omeprazole suspension for infants with gastroesophageal reflux disease. A pilot study].
    Orsi M; Donato G; Busoni V; Naisberg G; Caruso N
    Acta Gastroenterol Latinoam; 2011 Jun; 41(2):111-8. PubMed ID: 21894724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maintenance therapy of gastroesophageal reflux disease patients with omeprazole.
    Tepes B; Stabuc B; Kocijancic B; Ivanusa M
    Hepatogastroenterology; 2009; 56(89):67-74. PubMed ID: 19453031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized prospective study comparing the efficacy of on-demand therapy versus continuous therapy for 6 months for long-term maintenance with omeprazole 20 mg in patients with gastroesophageal reflux disease in Japan.
    Nagahara A; Hojo M; Asaoka D; Sasaki H; Watanabe S
    Scand J Gastroenterol; 2014 Apr; 49(4):409-17. PubMed ID: 24444414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Omeprazole-Mg 20.6 mg is superior to lansoprazole 15 mg for control of gastric acid: a comparison of over-the-counter doses of proton pump inhibitors.
    Miner PB; McKean LA; Gibb RD; Erasala GN; Ramsey DL; McRorie JW
    Aliment Pharmacol Ther; 2010 Apr; 31(8):846-51. PubMed ID: 20146702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Safety of proton pump inhibitors for long-term application].
    Kuipers E
    Eksp Klin Gastroenterol; 2006; (4):48-52. PubMed ID: 17269424
    [No Abstract]   [Full Text] [Related]  

  • 8. Omeprazole improves peak expiratory flow rate and quality of life in asthmatics with gastroesophageal reflux.
    Levin TR; Sperling RM; McQuaid KR
    Am J Gastroenterol; 1998 Jul; 93(7):1060-3. PubMed ID: 9672330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomised clinical trial: efficacy of the addition of a prokinetic, mosapride citrate, to omeprazole in the treatment of patients with non-erosive reflux disease - a double-blind, placebo-controlled study.
    Miwa H; Inoue K; Ashida K; Kogawa T; Nagahara A; Yoshida S; Tano N; Yamazaki Y; Wada T; Asaoka D; Fujita T; Tanaka J; Shimatani T; Manabe N; Oshima T; Haruma K; Azuma T; Yokoyama T;
    Aliment Pharmacol Ther; 2011 Feb; 33(3):323-32. PubMed ID: 21118395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality of life during acute and intermittent treatment of gastro-oesophageal reflux disease with omeprazole compared with ranitidine. Results from a multicentre clinical trial. The European Study Group.
    Wiklund I; Bardhan KD; Müller-Lissner S; Bigard MA; Bianchi Porro G; Ponce J; Hosie J; Scott M; Weir D; Fulton C; Gillon K; Peacock R
    Ital J Gastroenterol Hepatol; 1998 Feb; 30(1):19-27. PubMed ID: 9615259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparative study of esomeprazole and omeprazole using for initialism therapy for elderly-senile and young-adulthood patients with GERD].
    Onuchina EV; Brikova SI; Rozhanskiĭ AA; Kazakova RV; Poshkaĭte IA; Peshkov DV; Bushkova EV; Tsukanov VV
    Eksp Klin Gastroenterol; 2009; (7):83-90. PubMed ID: 20469712
    [No Abstract]   [Full Text] [Related]  

  • 12. [Delayed increase of serum gastrin level during prolonged treatment with omeprazole: two cases].
    Bardou M; Mallet L; Terris G
    Gastroenterol Clin Biol; 1995 May; 19(5):542-3. PubMed ID: 7590009
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical trial: the effects of adding ranitidine at night to twice daily omeprazole therapy on nocturnal acid breakthrough and acid reflux in patients with systemic sclerosis--a randomized controlled, cross-over trial.
    Janiak P; Thumshirn M; Menne D; Fox M; Halim S; Fried M; Brühlmann P; Distler O; Schwizer W
    Aliment Pharmacol Ther; 2007 Nov; 26(9):1259-65. PubMed ID: 17944740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of famotidine and omeprazole in healing symptoms of non-erosive gastro-oesophageal reflux disease: randomized-controlled study of gastro-oesophageal reflux disease.
    Wada T; Sasaki M; Kataoka H; Tanida S; Itoh K; Ogasawara N; Oshima T; Togawa S; Kubota E; Yamada T; Mori Y; Fujita F; Ohara H; Nakao H; Sobue S; Joh T; Itoh M
    Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():2-9. PubMed ID: 15943840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of patients with heartburn without endoscopic evaluation: on-demand treatment after effective continuous administration of lansoprazole 15 mg.
    Bigard MA; Genestin E
    Aliment Pharmacol Ther; 2005 Oct; 22(7):635-43. PubMed ID: 16181303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Association of gastroesophageal reflux and chronic laryngitis].
    Jaspersen D; Weber R; Hammar CH; Draf W
    Leber Magen Darm; 1995 Sep; 25(5):218-9. PubMed ID: 7500809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Omeprazole for gastroesophageal reflux disease in the first 2 years of life: a dose-finding study with dual-channel pH monitoring.
    Bishop J; Furman M; Thomson M
    J Pediatr Gastroenterol Nutr; 2007 Jul; 45(1):50-5. PubMed ID: 17592364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Omeprazole/amoxicillin versus triple therapy for Helicobacter pylori in duodenal ulcer disease: two-year follow-up of a prospective randomized study.
    Labenz J; Stolte M; Peitz U; Tillenburg B; Köhl H; Becker T; Börsch G
    Z Gastroenterol; 1995 Oct; 33(10):590-3. PubMed ID: 7502551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monitoring of omeprazole treatment in gastro-oesophageal reflux disease.
    Hendel J; Hendel L; Hage E; Hendel J; Aggestrup S; Nielsen OH
    Eur J Gastroenterol Hepatol; 1996 May; 8(5):417-20. PubMed ID: 8804867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Empiric trial of high-dose omeprazole in patients with posterior laryngitis: a prospective study.
    Wo JM; Grist WJ; Gussack G; Delgaudio JM; Waring JP
    Am J Gastroenterol; 1997 Dec; 92(12):2160-5. PubMed ID: 9399745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.